Genomictree Inc. (228760) — Cash Flow Reinvestment Rate

Latest as of December 2022: 3.71x

Genomictree Inc. (228760) has a Cash Flow Reinvestment Rate of 3.71x as of December 2022, reinvesting ₩15.89 Billion (capex ₩1.82 Billion plus investments ₩14.07 Billion) from operating cash flow of ₩4.29 Billion. See Genomictree Inc. (228760) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

3.71x

(Capex + Investments) / Operating CF

Total Reinvested

₩15.89 Billion

Capex + Investments

Operating Cash Flow

₩4.29 Billion

KRW

Capital Expenditures

₩1.82 Billion

KRW

Genomictree Inc. Cash Flow Reinvestment Rate (2022–2022)

Historical reinvestment intensity for Genomictree Inc. across 1 annual periods. For the full cash flow conversion analysis, see Genomictree Inc. (228760) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Genomictree Inc. (2022–2022)

Year-by-year capital reinvestment analysis for Genomictree Inc.. See Genomictree Inc. (228760) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2022	3.71x	₩15.89 Billion	₩4.29 Billion	₩1.82 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow